Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters

Laurence Slama, Frank J. Palella, Alison G. Abraham, Xiuhong Li, Corinne Vigouroux, Gilles Pialoux, Lawrence Kingsley, Jordan E. Lake, Todd T. Brown

Research output: Contribution to journalArticle

Abstract

BACKGROUND: There is limited evidence that among HIV-infected patients haemoglobin A1c (HbA1c) values may not accurately reflect glycaemia. We assessed HbA1c discordance (observed HbA1c - expected HbA1c) and associated factors among HIV-infected participants in the Multicenter AIDS Cohort Study (MACS).

METHODS: Fasting glucose (FG) and HbA1c were measured at each semi-annual MACS visit since 1999. All HIV-infected and HIV-uninfected men for whom at least one FG and HbA1c pair measurement was available were evaluated. Univariate median regression determined the association between HbA1c and FG by HIV serostatus. The relationship between HbA1c and FG in HIV-uninfected men was used to determine the expected HbA1c. Generalized estimating equations determined factors associated with the Hb1Ac discordance among HIV-infected men. Clinically significant discordance was defined as observed HbA1c - expected HbA1c ≤-0.5%.

RESULTS: Over 13 years, 1500 HIV-uninfected and 1357 HIV-infected men were included, with a median of 11 visits for each participant. At an FG of 125 mg/dL, the median HbA1c among HIV-infected men was 0.21% lower than among HIV-uninfected men and the magnitude of this effect increased with FG >126 mg/dL. Sixty-three percent of HIV-infected men had at least one visit with clinically significant HbA1c discordance, which was independently associated with: low CD4 cell count (

CONCLUSION: HbA1c underestimates glycaemia in HIV-infected patients and its use in patients with risk factors for HbA1c discordance may lead to under-diagnosis and to under-treatment of established diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)3360-3367
Number of pages8
JournalThe Journal of antimicrobial chemotherapy
Volume69
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

CD4 Lymphocyte Count
Hemoglobins
HIV
Fasting
Therapeutics
Glucose
Acquired Immunodeficiency Syndrome
Cohort Studies
Diabetes Mellitus

Keywords

  • diabetes
  • glycosylated haemoglobin
  • HbA1c
  • HIV
  • mean corpuscular volume

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inaccuracy of haemoglobin A1c among HIV-infected men : effects of CD4 cell count, antiretroviral therapies and haematological parameters. / Slama, Laurence; Palella, Frank J.; Abraham, Alison G.; Li, Xiuhong; Vigouroux, Corinne; Pialoux, Gilles; Kingsley, Lawrence; Lake, Jordan E.; Brown, Todd T.

In: The Journal of antimicrobial chemotherapy, Vol. 69, No. 12, 01.12.2014, p. 3360-3367.

Research output: Contribution to journalArticle

Slama, Laurence ; Palella, Frank J. ; Abraham, Alison G. ; Li, Xiuhong ; Vigouroux, Corinne ; Pialoux, Gilles ; Kingsley, Lawrence ; Lake, Jordan E. ; Brown, Todd T. / Inaccuracy of haemoglobin A1c among HIV-infected men : effects of CD4 cell count, antiretroviral therapies and haematological parameters. In: The Journal of antimicrobial chemotherapy. 2014 ; Vol. 69, No. 12. pp. 3360-3367.
@article{b83c06207ef346db961a3ed89bc9ad0e,
title = "Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters",
abstract = "BACKGROUND: There is limited evidence that among HIV-infected patients haemoglobin A1c (HbA1c) values may not accurately reflect glycaemia. We assessed HbA1c discordance (observed HbA1c - expected HbA1c) and associated factors among HIV-infected participants in the Multicenter AIDS Cohort Study (MACS).METHODS: Fasting glucose (FG) and HbA1c were measured at each semi-annual MACS visit since 1999. All HIV-infected and HIV-uninfected men for whom at least one FG and HbA1c pair measurement was available were evaluated. Univariate median regression determined the association between HbA1c and FG by HIV serostatus. The relationship between HbA1c and FG in HIV-uninfected men was used to determine the expected HbA1c. Generalized estimating equations determined factors associated with the Hb1Ac discordance among HIV-infected men. Clinically significant discordance was defined as observed HbA1c - expected HbA1c ≤-0.5{\%}.RESULTS: Over 13 years, 1500 HIV-uninfected and 1357 HIV-infected men were included, with a median of 11 visits for each participant. At an FG of 125 mg/dL, the median HbA1c among HIV-infected men was 0.21{\%} lower than among HIV-uninfected men and the magnitude of this effect increased with FG >126 mg/dL. Sixty-three percent of HIV-infected men had at least one visit with clinically significant HbA1c discordance, which was independently associated with: low CD4 cell count (CONCLUSION: HbA1c underestimates glycaemia in HIV-infected patients and its use in patients with risk factors for HbA1c discordance may lead to under-diagnosis and to under-treatment of established diabetes mellitus.",
keywords = "diabetes, glycosylated haemoglobin, HbA1c, HIV, mean corpuscular volume",
author = "Laurence Slama and Palella, {Frank J.} and Abraham, {Alison G.} and Xiuhong Li and Corinne Vigouroux and Gilles Pialoux and Lawrence Kingsley and Lake, {Jordan E.} and Brown, {Todd T.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1093/jac/dku295",
language = "English (US)",
volume = "69",
pages = "3360--3367",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Inaccuracy of haemoglobin A1c among HIV-infected men

T2 - effects of CD4 cell count, antiretroviral therapies and haematological parameters

AU - Slama, Laurence

AU - Palella, Frank J.

AU - Abraham, Alison G.

AU - Li, Xiuhong

AU - Vigouroux, Corinne

AU - Pialoux, Gilles

AU - Kingsley, Lawrence

AU - Lake, Jordan E.

AU - Brown, Todd T.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - BACKGROUND: There is limited evidence that among HIV-infected patients haemoglobin A1c (HbA1c) values may not accurately reflect glycaemia. We assessed HbA1c discordance (observed HbA1c - expected HbA1c) and associated factors among HIV-infected participants in the Multicenter AIDS Cohort Study (MACS).METHODS: Fasting glucose (FG) and HbA1c were measured at each semi-annual MACS visit since 1999. All HIV-infected and HIV-uninfected men for whom at least one FG and HbA1c pair measurement was available were evaluated. Univariate median regression determined the association between HbA1c and FG by HIV serostatus. The relationship between HbA1c and FG in HIV-uninfected men was used to determine the expected HbA1c. Generalized estimating equations determined factors associated with the Hb1Ac discordance among HIV-infected men. Clinically significant discordance was defined as observed HbA1c - expected HbA1c ≤-0.5%.RESULTS: Over 13 years, 1500 HIV-uninfected and 1357 HIV-infected men were included, with a median of 11 visits for each participant. At an FG of 125 mg/dL, the median HbA1c among HIV-infected men was 0.21% lower than among HIV-uninfected men and the magnitude of this effect increased with FG >126 mg/dL. Sixty-three percent of HIV-infected men had at least one visit with clinically significant HbA1c discordance, which was independently associated with: low CD4 cell count (CONCLUSION: HbA1c underestimates glycaemia in HIV-infected patients and its use in patients with risk factors for HbA1c discordance may lead to under-diagnosis and to under-treatment of established diabetes mellitus.

AB - BACKGROUND: There is limited evidence that among HIV-infected patients haemoglobin A1c (HbA1c) values may not accurately reflect glycaemia. We assessed HbA1c discordance (observed HbA1c - expected HbA1c) and associated factors among HIV-infected participants in the Multicenter AIDS Cohort Study (MACS).METHODS: Fasting glucose (FG) and HbA1c were measured at each semi-annual MACS visit since 1999. All HIV-infected and HIV-uninfected men for whom at least one FG and HbA1c pair measurement was available were evaluated. Univariate median regression determined the association between HbA1c and FG by HIV serostatus. The relationship between HbA1c and FG in HIV-uninfected men was used to determine the expected HbA1c. Generalized estimating equations determined factors associated with the Hb1Ac discordance among HIV-infected men. Clinically significant discordance was defined as observed HbA1c - expected HbA1c ≤-0.5%.RESULTS: Over 13 years, 1500 HIV-uninfected and 1357 HIV-infected men were included, with a median of 11 visits for each participant. At an FG of 125 mg/dL, the median HbA1c among HIV-infected men was 0.21% lower than among HIV-uninfected men and the magnitude of this effect increased with FG >126 mg/dL. Sixty-three percent of HIV-infected men had at least one visit with clinically significant HbA1c discordance, which was independently associated with: low CD4 cell count (CONCLUSION: HbA1c underestimates glycaemia in HIV-infected patients and its use in patients with risk factors for HbA1c discordance may lead to under-diagnosis and to under-treatment of established diabetes mellitus.

KW - diabetes

KW - glycosylated haemoglobin

KW - HbA1c

KW - HIV

KW - mean corpuscular volume

UR - http://www.scopus.com/inward/record.url?scp=84964026359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964026359&partnerID=8YFLogxK

U2 - 10.1093/jac/dku295

DO - 10.1093/jac/dku295

M3 - Article

C2 - 25096078

AN - SCOPUS:84964026359

VL - 69

SP - 3360

EP - 3367

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 12

ER -